首页|浅析肝脏影像报告及数据系统在肝细胞癌诊治中的关键应用及挑战

浅析肝脏影像报告及数据系统在肝细胞癌诊治中的关键应用及挑战

扫码查看
原发性肝癌是全球范围内发病率居第6位、死亡率居第3位的恶性肿瘤,肝细胞癌(hepatocellular carcinoma,HCC)是其中最主要的组织病理学亚型.肝脏影像报告及数据系统(Liver Imaging Reporting and Data System,LI-RADS)旨在规范高危患者肝脏病变的影像术语、图像采集、征象判读、报告书写及数据收集,实现局灶性肝脏病变的可靠分类,现已应用于包括诊断、生物学行为评估、预后预测、疗效评价等在内的HCC诊疗全程.本文旨在综述近期CT/MRI LI-RADS在HCC诊断、生物学行为评估及预后评价中的关键应用,浅析相关领域的现存挑战及未来可能的发展方向.
LI-RADS in the diagnosis and treatment of hepatocellular carcinoma:current and future perspectives
Primary liver cancer is the sixth most common malignancy and the third leading cause of cancer-related death worldwide,and hepatocellular carcinoma(HCC)constitutes the majority of primary liver cancer cases.The Liver Imaging Reporting and Data System(LI-RADS)was introduced to standardize the lexicon,acquisition,interpretation,reporting,and data collection of imaging results in patients at increased risk for HCC.LI-RADS allows effective categorization of focal liver lesions,and has been applied in the full clinical spectrum of HCC from diagnosis,biological behavior characterization,prognosis prediction,to treatment response assessment.This review aimed to summarize the recent applications of CT/MRI LI-RADS in the diagnosis,biological behavior characterization and prognosis prediction of HCC,discuss current challenges and shed light on potential future directions.

hepatocellular carcinomaLiver Imaging Reporting and Data Systemdiagnosisprognosis

蒋涵羽、陈卫霞

展开 >

四川大学华西医院放射科(成都 610041)

肝细胞癌 肝脏影像报告及数据系统 诊断 预后

2024

中国普外基础与临床杂志
四川大学华西医院

中国普外基础与临床杂志

CSTPCD
影响因子:0.858
ISSN:1007-9424
年,卷(期):2024.31(3)
  • 47